About Eton Bioscience
Eton Bioscience is a company based in San Diego (United States) founded in 2003 was acquired by Telesis Bio in November 2021. The company has 33 employees as of December 31, 2021. Eton Bioscience operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter San Diego, United States
- Employees 33 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
33
as on Dec 31, 2021
-
Acquired by
Telesis Bio
(Nov 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Eton Bioscience
Unlock access to complete
Leadership Team
1 people
Branch Team
1 people
Software Development Team
1 people
Account Team
1 people
Unlock access to complete
Funding Insights of Eton Bioscience
Detailed funding history for Eton Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Eton Bioscience
Eton Bioscience has secured backing from 1 investor. Prominent investors backing the company include Telesis Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Online platform offering life sciences reagents and kits
|
Locked | Locked | Locked |
Investor details for Eton Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eton Bioscience
Investment portfolio details for Eton Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eton Bioscience
Detailed financials for Eton Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eton Bioscience Comparisons
Peer comparison for Eton Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eton Bioscience
Eton Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Eton Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eton Bioscience
Complete news archive for Eton Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eton Bioscience
Eton Bioscience was founded in 2003.
Eton Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Steve Keller is the current CEO of Eton Bioscience.
As of Dec 31, 2021, the latest employee count at Eton Bioscience is 33.
Eton Bioscience was founded in 2003 in San Diego, United States. Operations are centered in the biotechnology sector, with emphasis on genomics. Services including DNA sequencing, oligo synthesis, peptide synthesis, and broader genomic offerings are provided. Products such as antibodies, peptides, metabolism assay kits, and cell lines are distributed. These activities support research applications in the field.
Eton Bioscience's top competitors include Novogene Corporation, BGI and Source BioScience.
Eton Bioscience has 1 investor. Key investors include Telesis Bio.